Salarius Pharmaceuticals, Inc. (SLRX)

0.6573 +0.02 (+3.35%) USD  |  NASDAQ  |  Dec 26, 16:00
0.6357 -0.02 (-3.29%) After-Hours: 20:00
More

Salarius Pharmaceuticals Amortization Expense CF (% of Quarterly Assets)

Amortization Expense CF (% of Quarterly Assets) Chart

View Amortization Expense CF (% of Quarterly Assets) for SLRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Amortization Expense CF (% of Quarterly Assets) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Amortization Expense CF (% of Quarterly Assets) Range, Past 5 Years

View Amortization Expense CF (% of Quarterly Assets) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Amortization Expense CF (% of Quarterly Assets) Benchmarks

View Amortization Expense CF (% of Quarterly Assets) Benchmarks
Start Trial
Eli Lilly & Co. --
CorMedix, Inc. Upgrade
Outset Medical, Inc. --
Vor Biopharma, Inc. --
Humacyte, Inc. --